Compare HALO & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | CFLT |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.7B |
| IPO Year | N/A | 2021 |
| Metric | HALO | CFLT |
|---|---|---|
| Price | $67.12 | $29.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 32 |
| Target Price | ★ $73.33 | $29.93 |
| AVG Volume (30 Days) | 2.6M | ★ 19.6M |
| Earning Date | 11-03-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 56.68 | N/A |
| EPS | ★ 4.74 | N/A |
| Revenue | ★ $1,242,852,000.00 | $1,113,149,000.00 |
| Revenue This Year | $34.83 | $22.76 |
| Revenue Next Year | $24.84 | $16.57 |
| P/E Ratio | $14.22 | ★ N/A |
| Revenue Growth | ★ 31.19 | 21.57 |
| 52 Week Low | $46.26 | $15.64 |
| 52 Week High | $79.50 | $37.90 |
| Indicator | HALO | CFLT |
|---|---|---|
| Relative Strength Index (RSI) | 54.13 | 77.28 |
| Support Level | $61.23 | $29.96 |
| Resistance Level | $66.60 | $30.07 |
| Average True Range (ATR) | 2.03 | 0.32 |
| MACD | 0.28 | 0.34 |
| Stochastic Oscillator | 81.90 | 96.74 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.